Pulse Biosciences (NASDAQ:PLSE) Upgraded to “Sell” at StockNews.com

StockNews.com upgraded shares of Pulse Biosciences (NASDAQ:PLSE – Free Report) to a sell rating in a research note issued to investors on Thursday. Pulse Biosciences Price Performance Shares of NASDAQ:PLSE opened at $17.14 on Thursday. Pulse Biosciences has a 12-month low of $6.59 and a 12-month high of $22.69. The business has a 50 day […]

Leave a Reply

Your email address will not be published.

Previous post Paycor HCM (NASDAQ:PYCR) Upgraded to “Outperform” at BMO Capital Markets
Next post Roper Technologies, Inc. (NYSE:ROP) Shares Sold by Stock Yards Bank & Trust Co.